5SJZ
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-N-(2-pyrrolidin-1-yl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-3-carboxamide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X10SA |
Synchrotron site | SLS |
Beamline | X10SA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2012-09-22 |
Detector | PSI PILATUS 6M |
Wavelength(s) | 1.000040 |
Spacegroup name | H 3 |
Unit cell lengths | 135.161, 135.161, 235.970 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 43.480 - 2.190 |
R-factor | 0.1731 |
Rwork | 0.170 |
R-free | 0.22600 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | inhouse model |
RMSD bond length | 0.012 |
RMSD bond angle | 1.748 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0258) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 43.480 | 43.480 | 2.250 |
High resolution limit [Å] | 2.190 | 9.790 | 2.190 |
Rmerge | 0.095 | 0.019 | 1.685 |
Rmeas | 0.106 | 0.021 | 1.874 |
Total number of observations | 428206 | ||
Number of reflections | 82722 | 921 | 6140 |
<I/σ(I)> | 12.84 | 61.16 | 1.05 |
Completeness [%] | 99.9 | 99 | 99.9 |
Redundancy | 5.176 | 5.131 | 5.233 |
CC(1/2) | 0.999 | 1.000 | 0.385 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 295 | 5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2 |